Research Reports
- 8/15/2024
2Q24 Reported With Focus On Influenza
- 7/19/2024
CDI-988 Reaches Milestone In Phase 1 Trial For Norovirus and Coronavirus
- 6/21/2024
Cocrystal Updates Studies On Influenza and Bird Flu
- 5/14/2024
1Q24 Reported With Clinical Data Milestones On Schedule
- 11/14/2023
3Q23 Reported As Three Trials Make Progress
- 11/1/2023
Phase 2a Influenza Trial Receives Authorization To Begin
- 10/2/2023
CDI-988 Begins Phase 1a/b Clinical Trial
- 8/15/2023
2Q23 Reported With New Clinical Trials Ready To Begin
- 5/15/2023
Products Are Advancing Toward Clinical Milestones
- 3/30/2023
FY2022 Reported With New Clinical Trials On Track
- 12/20/2022
Safety and Tolerability Data From Influenza Study Announced
- 11/16/2022
3Q22 Reported – First Influenza Vaccine Data To Be Presented